GoodRX stocks grow after a strike agreement to sell Novo Nordisk GLP-1 for $ 499/month
The GoodRX (GDRX) on Monday joins the GLP-1 action with a report that it will start selling both Novo Nordisk (NGO) GLP-1 drugs, Ozempic for diabetes and Wegovy for weight loss at a net price of $ 499 per month. Partnership occurs when remote health and digital health platforms are increasingly regarded as ways to … Read more